A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: Application of the CD3/CD28 assay in lymphocytes

Goldstein, 2001, Familial hypercholesterolemia, 2863 Soutar, 2007, Mechanisms of disease: genetic causes of familial hypercholesterolemia, Nat Pract Cardiovasc Med, 4, 214, 10.1038/ncpcardio0836 Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311 Südhof, 1985, The LDL receptor gene: a mosaic of exons shared with different proteins, Science, 228, 815, 10.1126/science.2988123 Südhof, 1985, Cassette of eight exons shared by genes for LDL receptor and EGF precursor, Science, 228, 893, 10.1126/science.3873704 Varret, 1999, A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32, Am J Hum Genet, 64, 1378, 10.1086/302370 Yu, 2002, Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population, Atherosclerosis, 165, 335, 10.1016/S0021-9150(02)00249-6 van Aalst-Cohen, 2006, Diagnosing familial hypercholesterolaemia: the relevance of genetic testing, Eur Heart J, 27, 2240, 10.1093/eurheartj/ehl113 Stephan, 1993, Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL, J Lipid Res, 34, 325, 10.1016/S0022-2275(20)40759-X Verhoeye, 1996, An improved method for detection of low density lipoprotein receptor defects in human T lymphocytes, J Lipid Res, 37, 1377, 10.1016/S0022-2275(20)39168-9 Raungaard, 2000, Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia, J Clin Pharmacol, 40, 421, 10.1177/00912700022009008 Ranheim, 2006, Model system for phenotypic characterization of sequence variations in the LDL receptor gene, Clin Chem, 52, 1469, 10.1373/clinchem.2006.068627 Iwasaki, 2004, The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor, J Hum Genet, 49, 622, 10.1007/s10038-004-0198-4 Soutar, 1989, Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and interacellular movement of receptors, Proc Natl Acad Sci U.S.A, 86, 4166, 10.1073/pnas.86.11.4166 Goldstein, 1976, Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans, Cell, 7, 85, 10.1016/0092-8674(76)90258-0 Suzuki, 1990, Augmentation of LDL receptor activities on lymphocytes by interleukin-2 and anti-CD3 antibody: flow cytometric analysis, Biochim Biophys Acta, 1042, 352, 10.1016/0005-2760(90)90164-S Trickett, 2003, T cell stimulation and expansion using anti-CD3/CD28 beads, J Immunol Methods, 275, 251, 10.1016/S0022-1759(03)00010-3 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Sun, 1997, Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group, Arterioscler Thromb Vasc Biol, 17, 3092, 10.1161/01.ATV.17.11.3092 Davis, 1987, The low density lipoprotein receptor. Identification of amino acids in cytoplasmic domain required for rapid endocytosis, J Biol Chem, 262, 4075, 10.1016/S0021-9258(18)61313-4 Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, N Engl J Med, 333, 1301, 10.1056/NEJM199511163332001 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators, N Engl J Med, 1335, 1001, 10.1056/NEJM199610033351401 Brown, 1983, Lipoprotein receptors in the liver: control signals for plasma cholesterol traffic, J Clin Invest, 72, 743, 10.1172/JCI111044 Reihnér, 1990, Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol, N Engl J Med, 323, 224, 10.1056/NEJM199007263230403 Raveh, 1990, Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins, Atherosclerosis, 82, 19, 10.1016/0021-9150(90)90139-A Hagemenas, 1990, The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolemia, Eur J Clin Invest, 20, 150, 10.1111/j.1365-2362.1990.tb02262.x